Loading
Total declarations
Company
▲ Purchases (21 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Dec 2025 for MAIA Biotechnology, Inc., €19k.
Filing timeline
BuySaleCristian Luput
Insider track record
Disclosed buys
21
Disclosed sells
0
Signal history
Closed purchases
Market purchases
14
Positive at T+90
100%
Median T+90
+81.9%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +75.4%Entry US$1.18 · Close at T+90 US$2.07
- -0.8%Entry US$1.20 · Close 06 Oct 2026 US$1.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cristian Luput: trading record in brief
Cristian Luput is a declared insider of MAIA Biotechnology, Inc., with filings sourced from SEC (Form 4). The record holds 21 filings, for trades running from 1 August 2022 to 28 November 2025.
Purchases make up the whole of the open-market record (21 purchases, €243k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2025, the count stands at 3 purchases and no sales.
The median purchase comes to €5,323. On 21 out of 21 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 1 December 2025, reports an open-market purchase of €17k in MAIA Biotechnology, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cristian Luput
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
20,000 shares@ US$1.08089.5% of flowCommon StockSEC:0001878313-25-000054:0
Canonical exit: 24 Feb 2026 (T+90)
10,000 shares@ US$0.97854.3% of flowCommon StockSEC:0001878313-25-000050:0
Canonical exit: 23 Feb 2026 (T+90)
22,133 shares@ US$2.5126.0% of flowCommon StockSEC:0001127602-24-026386:0
Canonical exit: 30 Jan 2025 (T+90)
69,282 shares@ US$1.1737.7% of flowCommon StockSEC:0001127602-24-010323:0
Canonical exit: 12 Jun 2024 (T+90)
3,000 shares@ US$2.633.7% of flowCommon StockSEC:0001127602-23-015796:0
Canonical exit: 13 Aug 2023 (T+90)
1,576 shares@ US$3.692.7% of flowCommon StockSEC:0001127602-23-013028:0
Canonical exit: 16 Jul 2023 (T+90)
622 shares@ US$3.621.0% of flowCommon StockSEC:0001127602-23-012944:0
Canonical exit: 12 Jul 2023 (T+90)
5,382 shares@ US$3.9910.3% of flowCommon StockSEC:0001127602-23-009989:0
Canonical exit: 8 Jun 2023 (T+90)
627 shares@ US$4.221.3% of flowCommon StockSEC:0001127602-23-009696:0
Canonical exit: 6 Jun 2023 (T+90)
527 shares@ US$4.241.1% of flowCommon StockSEC:0001127602-23-009395:0
Canonical exit: 4 Jun 2023 (T+90)
58 shares@ US$4.250.1% of flowCommon StockSEC:0001127602-23-006043:0
Canonical exit: 17 May 2023 (T+90)
14 shares@ US$4.250.0% of flowCommon StockSEC:0001127602-23-005438:0
Canonical exit: 15 May 2023 (T+90)
504 shares@ US$3.880.9% of flowCommon StockSEC:0001127602-23-001508:0
Canonical exit: 13 Apr 2023 (T+90)
500 shares@ US$5.001.2% of flowCommon StockSEC:0000899243-22-027452:0
Canonical exit: 30 Oct 2022 (T+90)
14 of 14 declarations
